Abstract
Hospitalization for acute heart failure syndromes (AHFS) is a growing health care burden. Over 1 million hospitalizations occur annually, with a postdischarge mortality and rehospitalization rate of ~45% by 90 days and a financial cost greater than $20 billion. Attempts to improve outcomes through novel therapies have largely failed, suggesting new approaches are needed. We review phase II studies in AHFS to identify opportunities for future development programs.
Original language | English (US) |
---|---|
Pages (from-to) | 441-450 |
Number of pages | 10 |
Journal | Heart Failure Clinics |
Volume | 7 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2011 |
Keywords
- Acute heart failure
- Clinical trials
- Phase 2
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine